• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刺激偏倚为 G 蛋白偶联受体结构中的构象约束提供了证据。

Stimulus bias provides evidence for conformational constraints in the structure of a G protein-coupled receptor.

机构信息

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, and Department of Pharmacology, Monash University, Victoria 3800, Australia.

出版信息

J Biol Chem. 2012 Oct 26;287(44):37066-77. doi: 10.1074/jbc.M112.408534. Epub 2012 Sep 10.

DOI:10.1074/jbc.M112.408534
PMID:22965232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3481307/
Abstract

A key characteristic of G protein-coupled receptors (GPCRs) is that they activate a plethora of signaling pathways. It is now clear that a GPCR coupling to these pathways can be regulated selectively by ligands that differentially drive signaling down one pathway in preference to another. This concept, termed stimulus bias, is revolutionizing receptor biology and drug discovery by providing a means of selectively targeting receptor signaling pathways that have therapeutic impact. Herein, we utilized a novel quantitative method that determines stimulus bias of synthetic GPCR ligands in a manner that nullifies the impact of both the cellular background and the "natural bias" of the endogenous ligand. By applying this method to the M(2) muscarinic acetylcholine receptor, a prototypical GPCR, we found that mutation of key residues (Tyr-80(2.61) and Trp-99(3.28)) in an allosteric binding pocket introduces stimulus bias in response to the atypical ligands AC-42 (4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)piperidine HCl) and 77-LH-28-1 (1-(3-(4-butyl-1-piperidinyl)propyl)- 3,3-dihydro-2(1H)-quinolinone). By comparing stimulus bias factors among receptor internalization, G protein activation, extracellular-regulated protein kinase 1/2 (ERK1/2) signaling, and receptor phosphorylation, we provide evidence that Tyr-80(2.61) and Trp-99(3.28) act either as molecular switches or as gatekeeper residues that introduce constraints limiting the active conformation of the M(2) muscarinic acetylcholine receptor and thereby regulate stimulus bias. Furthermore, we provide evidence that downstream signaling pathways previously considered to be related to each other (i.e. receptor phosphorylation, internalization, and activation of ERK1/2) can act independently.

摘要

G 蛋白偶联受体 (GPCRs) 的一个关键特征是它们能够激活大量的信号通路。现在已经很清楚,配体可以选择性地调节这些通路与 GPCR 的偶联,从而优先驱动信号传递到一条通路而不是另一条通路。这种被称为刺激偏向的概念,通过提供一种选择性靶向具有治疗影响的受体信号通路的方法,正在彻底改变受体生物学和药物发现。在此,我们利用一种新的定量方法,以一种消除细胞背景和内源性配体“天然偏向”影响的方式,确定了合成 GPCR 配体的刺激偏向。通过将这种方法应用于 M2 毒蕈碱乙酰胆碱受体,一种典型的 GPCR,我们发现,在变构结合口袋中的关键残基 (Tyr-80(2.61) 和 Trp-99(3.28)) 突变后,会导致对非典型配体 AC-42(4-正丁基-1-(4-(2-甲基苯基)-4-氧代-1-丁基)哌啶盐酸盐)和 77-LH-28-1(1-(3-(4-正丁基-1-哌啶基)丙基)-3,3-二氢-2(1H)-喹啉酮)的刺激偏向。通过比较受体内化、G 蛋白激活、细胞外调节蛋白激酶 1/2(ERK1/2)信号和受体磷酸化之间的刺激偏向因子,我们提供了证据表明 Tyr-80(2.61)和 Trp-99(3.28) 作为分子开关或作为门控残基起作用,这些残基引入了限制 M2 毒蕈碱乙酰胆碱受体的活性构象的限制,并由此调节刺激偏向。此外,我们提供了证据表明,先前被认为相互关联的下游信号通路(即受体磷酸化、内化和 ERK1/2 的激活)可以独立发挥作用。

相似文献

1
Stimulus bias provides evidence for conformational constraints in the structure of a G protein-coupled receptor.刺激偏倚为 G 蛋白偶联受体结构中的构象约束提供了证据。
J Biol Chem. 2012 Oct 26;287(44):37066-77. doi: 10.1074/jbc.M112.408534. Epub 2012 Sep 10.
2
Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.鉴定 M2 毒蕈碱乙酰胆碱受体的变构和变构部位突变,这些突变导致配体选择性信号转导偏倚。
J Biol Chem. 2010 Mar 5;285(10):7459-74. doi: 10.1074/jbc.M109.094011. Epub 2010 Jan 5.
3
Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.M2型毒蕈碱型乙酰胆碱受体变构激动作用的结构-功能研究
Mol Pharmacol. 2007 Aug;72(2):463-76. doi: 10.1124/mol.107.037630. Epub 2007 May 24.
4
Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.变构激动剂和正构激动剂对M1毒蕈碱型乙酰胆碱受体内化和下调的对比作用。
J Pharmacol Exp Ther. 2009 Dec;331(3):1086-95. doi: 10.1124/jpet.109.160242. Epub 2009 Sep 18.
5
G protein coupling and signaling pathway activation by m1 muscarinic acetylcholine receptor orthosteric and allosteric agonists.M1毒蕈碱型乙酰胆碱受体的正构和变构激动剂介导的G蛋白偶联及信号通路激活
J Pharmacol Exp Ther. 2008 Nov;327(2):365-74. doi: 10.1124/jpet.108.141788. Epub 2008 Jul 29.
6
Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.新型 M1 毒蕈碱型乙酰胆碱受体选择性激动剂的变构和变构外作用模式。
Mol Pharmacol. 2010 Jul;78(1):94-104. doi: 10.1124/mol.110.064345. Epub 2010 Apr 22.
7
Conformational changes in the M2 muscarinic receptor induced by membrane voltage and agonist binding.M2 毒蕈碱型乙酰胆碱受体构象变化:由膜电压和激动剂结合诱导。
J Physiol. 2011 Apr 1;589(Pt 7):1741-53. doi: 10.1113/jphysiol.2010.204107. Epub 2011 Jan 31.
8
New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.新型放射性配体 [³H]iperoxo 对活性毒蕈碱型受体的新认识。
Biochem Pharmacol. 2014 Aug 1;90(3):307-19. doi: 10.1016/j.bcp.2014.05.012. Epub 2014 May 23.
9
Muscarinic acetylcholine receptor-mediated phosphorylation of extracellular signal-regulated kinase in HSY salivary ductal cells involves distinct signaling pathways.毒蕈碱型乙酰胆碱受体介导的细胞外信号调节激酶在 HSY 涎腺导管细胞中的磷酸化作用涉及不同的信号通路。
J Oral Biosci. 2024 Jun;66(2):447-455. doi: 10.1016/j.job.2024.02.002. Epub 2024 Feb 8.
10
Conformational Complexity and Dynamics in a Muscarinic Receptor Revealed by NMR Spectroscopy.通过 NMR 光谱揭示了毒蕈碱型乙酰胆碱受体的构象复杂性和动态性。
Mol Cell. 2019 Jul 11;75(1):53-65.e7. doi: 10.1016/j.molcel.2019.04.028. Epub 2019 May 15.

引用本文的文献

1
G protein signaling-biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists.G 蛋白信号偏向性 μ 阿片受体激动剂,可产生持续的 G 蛋白激活,是非竞争性激动剂。
Proc Natl Acad Sci U S A. 2021 Nov 30;118(48). doi: 10.1073/pnas.2102178118.
2
Non-visual Opsins and Novel Photo-Detectors in the Vertebrate Inner Retina Mediate Light Responses Within the Blue Spectrum Region.脊椎动物视网膜内层的非视觉视蛋白和新型光探测器介导蓝光光谱区域内的光反应。
Cell Mol Neurobiol. 2022 Jan;42(1):59-83. doi: 10.1007/s10571-020-00997-x. Epub 2020 Nov 24.
3
Biased agonists at the human Y receptor lead to prolonged membrane residency and extended receptor G protein interaction.在人类 Y 受体上具有偏向激动活性的配体导致延长的膜居留时间和延长的受体-G 蛋白相互作用。
Cell Mol Life Sci. 2020 Nov;77(22):4675-4691. doi: 10.1007/s00018-019-03432-7. Epub 2020 Jan 9.
4
Family C G-Protein-Coupled Receptors in Alzheimer's Disease and Therapeutic Implications.阿尔茨海默病中的C类G蛋白偶联受体及其治疗意义
Front Pharmacol. 2019 Oct 28;10:1282. doi: 10.3389/fphar.2019.01282. eCollection 2019.
5
Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors.变构机制中的信号传导:G蛋白偶联受体内的信号传递途径
Molecules. 2017 Jul 15;22(7):1188. doi: 10.3390/molecules22071188.
6
Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptor.双位配体与M1毒蕈碱型乙酰胆碱受体结合的分子机制
J Biol Chem. 2014 Aug 22;289(34):23817-37. doi: 10.1074/jbc.M114.582874. Epub 2014 Jul 8.
7
Recent developments in biased agonism.最近在偏向激动剂方面的进展。
Curr Opin Cell Biol. 2014 Apr;27:18-24. doi: 10.1016/j.ceb.2013.10.008. Epub 2013 Nov 20.
8
Endocytic profiles of δ-opioid receptor ligands determine the duration of rapid but not sustained cAMP responses.δ-阿片受体配体的内吞特征决定了快速但非持续的 cAMP 反应的持续时间。
Mol Pharmacol. 2014 Jan;85(1):148-61. doi: 10.1124/mol.113.089003. Epub 2013 Oct 30.
9
Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists.配体和细胞依赖性决定因素对内源性阿片受体(DOR)激动剂内化和 cAMP 调节的影响。
Cell Mol Life Sci. 2014 Apr;71(8):1529-46. doi: 10.1007/s00018-013-1461-7.
10
The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism.TUG-891 是一种强效和选择性游离脂肪酸受体 4(FFA4/GPR120)激动剂,其药理学既展示了治疗性激动作用的潜在机会,也提出了可能的挑战。
Mol Pharmacol. 2013 Nov;84(5):710-25. doi: 10.1124/mol.113.087783. Epub 2013 Aug 26.

本文引用的文献

1
A simple method for quantifying functional selectivity and agonist bias.一种量化功能选择性和激动剂偏向性的简单方法。
ACS Chem Neurosci. 2012 Mar 21;3(3):193-203. doi: 10.1021/cn200111m. Epub 2011 Dec 20.
2
Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.七跨膜受体β-arrestin 偏向激动剂的分子机制。
Annu Rev Pharmacol Toxicol. 2012;52:179-97. doi: 10.1146/annurev.pharmtox.010909.105800. Epub 2011 Sep 19.
3
β-Arrestin-mediated receptor trafficking and signal transduction.β-arrestin 介导的受体转运和信号转导。
Trends Pharmacol Sci. 2011 Sep;32(9):521-33. doi: 10.1016/j.tips.2011.05.002. Epub 2011 Jun 15.
4
Quantifying ligand bias at seven-transmembrane receptors.量化七跨膜受体的配体偏向性。
Mol Pharmacol. 2011 Sep;80(3):367-77. doi: 10.1124/mol.111.072801. Epub 2011 May 24.
5
'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass?甲状旁腺激素受体“偏倚”:增加骨量的新型合成代谢方法?
Br J Pharmacol. 2011 Sep;164(1):59-67. doi: 10.1111/j.1476-5381.2011.01450.x.
6
Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits β-arrestin without activating G proteins.组胺 H4 受体的激动剂偏向信号传导:JNJ7777120 募集β-arrestin 而不激活 G 蛋白。
Mol Pharmacol. 2011 Apr;79(4):749-57. doi: 10.1124/mol.110.068395. Epub 2010 Dec 6.
7
Quantification of functional selectivity at the human α(1A)-adrenoceptor.人 α(1A)-肾上腺素能受体功能选择性的定量分析。
Mol Pharmacol. 2011 Feb;79(2):298-307. doi: 10.1124/mol.110.067454. Epub 2010 Oct 26.
8
Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.选择性地在血管紧张素 II 型 1 受体上结合β-arrestin 可降低血压并提高心脏功能。
J Pharmacol Exp Ther. 2010 Dec;335(3):572-9. doi: 10.1124/jpet.110.173005. Epub 2010 Aug 26.
9
Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening.胰高血糖素样肽 1 受体 (GLP-1R) 的变构配体以一种途径选择性的方式差异调节内源性和外源性肽的反应:对药物筛选的影响。
Mol Pharmacol. 2010 Sep;78(3):456-65. doi: 10.1124/mol.110.065664. Epub 2010 Jun 14.
10
Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.新型 M1 毒蕈碱型乙酰胆碱受体选择性激动剂的变构和变构外作用模式。
Mol Pharmacol. 2010 Jul;78(1):94-104. doi: 10.1124/mol.110.064345. Epub 2010 Apr 22.